Mynd Healthcare

Library / regulatory-reference

Mexico: Federal Commission for Protection against Health Risks (COFEPRIS)

Audience: administrators-policy, researchers-scientists ยท Review state: published

The national authority

The Federal Commission for Protection against Health Risks, known as COFEPRIS, is Mexico's national regulator for medicines, medical devices, food safety and a broad range of health-risk matters, operating under the federal health ministry.

Its remit is unusually wide: beyond product registration it covers advertising of health products, sanitary licensing of establishments, and health surveillance across the country.

How products enter the market

Medicines require a sanitary registration granted after evaluation of quality, safety and efficacy, and Mexico has developed reliance pathways that give credit to assessments by certain trusted foreign regulators, allowing faster review of products already approved elsewhere.

Medical devices require sanitary registration as well, with classification and requirements scaling by risk, and COFEPRIS inspects manufacturing and distribution establishments as part of its licensing remit.

Regional and international role

COFEPRIS is one of Latin America's most influential regulators: its decisions are watched across the Spanish-speaking region, and it participates in international harmonization work on medicines and devices.

Mexico's large domestic market and its position between North and Latin America give its regulatory choices weight beyond its borders, particularly for generic medicines and biosimilars policy.

Using this profile

COFEPRIS publishes its registers, guidance and communications in Spanish through the federal government portal, which is the primary source for current rules and listed in this profile's internal reference record.

For cross-country comparison: COFEPRIS illustrates the broad-remit Latin American regulator, combining product registration with advertising control and sanitary surveillance, and increasingly using reliance on trusted foreign assessments to manage its workload.

Limitations

Educational profile of a national regulatory system, current as of drafting. It simplifies routes and classes and is not legal, regulatory, or clinical advice. Filing and compliance decisions must be confirmed against the authority's current published rules and, where needed, professional regulatory counsel.